Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Outline of Final Research Achievements |
To construct the enzyme assay system, the lipid nanoparticle luminescent device (LNPLD) modified glutathione (GSH) as a substrate (GSH-LNPLD) has been developed for the determination of γ-glutamyltransferase (γ-GT). In the γ-GT concentration range of 0.1-0.4 U, the GSH-LNPLD system had a linearity between the γ-GT concentration and luminescent intensity. This study showed that the GSH-LNPLD system has a possibility applicable for the γ-GT assay, although the sensitivity of the GSH-LNPLD system is low to use in clinical site.
|